![]() |
Formats:
|
||||||||||||||||||
Copyright © Springer Science+Business Media B.V. 2007 Evaluating the discriminatory power of EQ-5D, HUI2 and HUI3 in a US general population survey using Shannon’s indices Public Health Epidemiology, Department of Social Medicine, Academic Medical Center, 22660, 1100 DD Amsterdam, The Netherlands Mathieu F. (Bas) Janssen, Phone: +31-20-5666695, Fax: +31-20-6972316, Email: m.f.janssen/at/amc.uva.nl. Corresponding author.Received January 24, 2006; Accepted December 19, 2006. Abstract Objectives To compare quantitatively the discriminatory power of the EQ-5D, HUI2 and HUI3 in terms of absolute and relative informativity, using Shannon’s indices. Methods EQ-5D and HUI2/3 data completed by a sample of the general adult US population (N = 3,691) were used. Five dimensions allowed head-to-head comparison of informativity: Mobility/Ambulation; Anxiety/Depression/Emotion; Pain/Discomfort (EQ-5D; HUI2; HUI3); Self-Care (EQ-5D; HUI2); and Cognition (HUI2; HUI3). Shannon’s index and Shannon’s Evenness index were used to assess absolute and relative informativity, both by dimension and by instrument as a whole. Results Absolute informativity was highest for HUI3, with the largest differences in Pain/Discomfort and Cognition. Relative informativity was highest for EQ-5D, with the largest differences in Mobility/Ambulation and Anxiety/Depression/Emotion. Absolute informativity by instrument was consistently highest for HUI3 and lowest for EQ-5D, and relative informativity was highest for EQ-5D and lowest for HUI3. Discussion Performance in terms of absolute and relative informativity of the common dimensions of the three instruments varies over dimensions. Several dimensions are suboptimal: Pain/Discomfort (EQ-5D) seems too crude with only 3 levels, and the level descriptions of Ambulation (HUI3) and Self-Care (HUI2) could be improved. In absence of a formal measure, Shannon’s indices provide useful measures for assessing discriminatory power of utility instruments. Keywords: Health status, Methodology, Psychometrics, Population health, Health-related quality-of-life Introduction The need for assessing health-related quality of life (HRQL) has brought forth hundreds of HRQL instruments, both generic and disease-specific [1, 2]. Generic instruments fall into two main categories: (1) preference-based health classification systems, and (2) non-preference based measures, sometimes referred to as health profile or psychometric measures [1, 3, 4]. Preference-based classification systems, also referred to as multi-attribute utility instruments (MAUIs) are standardized health state classifications that can be used to obtain a single summary index (utility score) or so-called preference weight for different health states. At the core of any MAUI is a classification system consisting of multiple attributes (dimensions) with ordered levels for each dimension. Most MAUIs are generic and aim to cover the full spectrum of disease and disability. MAUIs are widely used as measures of health outcome and are applied in clinical and economic evaluation (to calculate QALYs) and in population health surveys. Three widely used MAUIs are the EQ-5D, the Health Utilities Index Mark 2 (HUI2) and the Health Utilities Index Mark 3 (HUI3) [5–7]. All three instruments have shown acceptable psychometric properties as established by conventional measures [8, 9]. Feasibility, reliability, validity and responsiveness are important measurement properties in MAUIs, just as they are in non-preference based HRQL and health status measures such as the SF-36. However, these properties may be operationalized differently in MAUIs compared to non-preference based measures [4, 10, 11]. An underlying property to the concepts of reliability, validity and responsiveness is the ability of an instrument to discriminate between (‘true’) different levels of health. This requires a MAUI to define the full range of potential health states, and to be sensitive over this range. A necessary measurement property for any health status measure (including MAUIs) is the ability to discriminate among people at a single point in time. This property is sometimes referred to as sensitivity or, more accurately: “discriminatory power” [12–14]. Guyatt et al. (1992) proposed a reliability coefficient as a suitable statistic to express discriminatory power [15]. Reliability essentially reflects two different concepts: (1) consistency, e.g. between raters (inter-rater reliability) or over time (test-retest reliability), and (2) discriminatory power: the ability of an instrument to discriminate among people [16]. We propose Shannon’s indices of informativity as suitable measures that solely reflect discriminatory power [17]. Discriminatory power of MAUIs is usually investigated in an informal and partial manner by examining the frequency distributions, e.g. for floor or ceiling effects [12, 13, 18–20]. Shannon’s indices are suitable to assess discriminatory power in MAUIs for two reasons: first, they are theoretically based and second, they incorporate the frequency distribution across all categories of a MAUI’s health status classification system (not just the highest and lowest categories, as is the case with ceiling and floor effects). Our aim is to investigate the discriminatory power of the EQ-5D, HUI2 and HUI3 in a general population sample, as expressed by Shannon’s indices. Informativity was assessed separately by dimension and by MAUI as a whole. Methods Data A publicly available dataset was used (at http://www.ahrq.gov/rice/), resulting from the US EQ-5D valuation study [21, 22]. Collected data consisted of self-completed EQ-5D and HUI2/3 data from a sample of the general adult US population, with an over-sampling of Hispanics and non-Hispanic Blacks. The HUI2/3 data were collected using a standardized 15-item questionnaire, from which HUI2 and HUI3 health profiles were extracted using available recoding algorithms [23]. Only the responses of 3,691 respondents who had no missing data on any of the three instruments were included in this study (91.2% of the total number of respondents). Instruments The EQ-5D descriptive system consists of 5 dimensions (items) with 3 levels each, logically defining 243 unique health states (permutations). The HUI2 was originally developed to assess outcomes in survivors of cancer in childhood and contains 6 dimensions (excluding the original HUI2 dimension of fertility) with 4–5 levels per dimension. The HUI3, originally developed for a general population health survey in Canada, has 8 dimensions with 5–6 levels per dimension. The HUI2 and HUI3 descriptive systems define 8,000 and 972,000 unique health states, respectively [6]. Table 1 compares the 5 dimensions common to at least two of the classification systems: Mobility/Ambulation; Anxiety/Depression/Emotion; Pain/Discomfort (EQ-5D; HUI2; HUI3); Self-Care (EQ-5D; HUI2); and Cognition (HUI2; HUI3).
Shannon’s indices: background and properties The Shannon index, named after Claude Shannon who is considered to be the founder of information theory, was initially developed to separate noise from information carrying signals in telecommunication systems [17]. The Shannon index is also known as the Shannon–Weaver index because of Warren Weaver’s contribution to Shannon’s original paper, and as the Shannon–Wiener index named after Norbert Wiener who independently developed a concept similar to Shannon’s [24, 25]. The Shannon index has been applied in a variety of fields, ranging from ecology (as a measure of biodiversity) to psychology, record linkage and molecular biology (genetic diversity) [26–30]. In information theory, the information of a signal is distinguished from the meaning or the semantic content of a signal. Rather, the information is quantified and is identified with uncertainty. Informativity is dependent on the number of classes (e.g. bits or response options) and the distribution of the observations (the ‘signal’) among classes. For classifications, this implies that if one would want to develop a useful (informative) distinction between, say, European countries, distinguishing between Scandinavian and non-Scandinavian countries would be far less informative than distinguishing between Northern, Western, Eastern and Southern European countries. Note that the latter classification not only contains more categories but the countries are also more evenly distributed among categories. The Shannon index is defined as:
The Shannon index combines the absolute information content as expressed by the number of categories with the extent to which the information is evenly spread over these categories. Shannon’s Evenness index (J′) exclusively reflects the latter component, i.e. the rectangularity of a distribution. This measure was first proposed by Lloyd and Ghelardi [32]; Shannon already referred to it as relative entropy and Pielou termed the concept ‘evenness’ [17, 33]. Shannon’s Evenness index (J′) is defined as: J′ = H′/H′max, which expresses the use of the system (H′) given its potential (H′max). Shannon’s index H′ can be considered as an expression of the absolute informativity of a system whereas Shannon’s Evenness index J′ expresses the relative informativity of a system or ‘evenness’ of a distribution, regardless the number of categories. Shannon indices applied to MAUIs The basic characteristics of Shannon’s indices which make them suitable to reflect discriminatory power have been documented and are explained as follows. In an item where a response option has a very high (or low) endorsement, e.g. p is over 0.95 (or under 0.05), one learns very little because one can predict with more than 95% certainty what the answer will be. In other words, there is very little information being transmitted. Conversely, the maximum amount of information (uncertainty) is being transmitted when, in an item with two response options, p is 0.50 for each response option. As described above, this characteristic of an even distribution underlies the Shannon indices. In case of an even distribution, the item (dimension) is being most efficiently used, which means that the discriminant ability of the level descriptors is maximal. The Shannon indices can be calculated by dimension separately or by MAUI as a whole. To calculate Shannon’s indices by dimension, levels are treated as categories, so C represents the number of levels (L), pi is the proportion of responses of the ith level, and H′max equals log2L. Suppose the EQ-5D Mobility dimension is scored by 10 respondents: no problems (n = 6), some problems (n = 3) and confined to bed (n = 1). Shannon’s index for Mobility is calculated as H′ = –((0.6 log2 0.6) + (0.3 log2 0.3) + (0.1 log2 0.1)) = 1.30 and H′max = log23 = 1.58, so J′ = 1.30/1.58 = 0.82. Figure 1
To calculate Shannon’s indices by instrument as a whole, permutations are treated as unique categories (e.g. 243 categories for EQ-5D), so C is the number of permutations (Pmax), pi is the proportion of the ith permutation, and H′max now equals log2Pmax. Since the number of observations in our study (N = 3,691) is lower than the number of theoretically possible permutations in HUI2 (8,000) and HUI3 (972,000), maximum informativity (H′max) in HUI2 and HUI3, and consequently maximum relative informativity J′ cannot be reached a priori. Therefore, Shannon’s indices by MAUI as a whole were calculated using an estimation approach. Assuming that the current sample is representative, subsamples of the original set of observed health states were drawn in order to estimate the number of different health states in hypothetical populations of 1, 10, and 100 million respondents, by means of extrapolation. This procedure was repeated for different proportions of the population in relation to the number of health states (e.g. 11 different EQ-5D health states accounted for a 90% proportion of the respondents), in order to estimate the shape of the frequency distribution in the hypothetical populations of 1, 10, and 100 million respondents. Finally, Shannon’s H′ and J′ could be calculated (details can be obtained from the authors). Results The mean age of the respondents was 42.9 years (range: 18.0–99.3 years), with 42.2% of the respondents being male. White (non-Hispanic) respondents were 1,435 (38.9%), non-Hispanic blacks were 1,018 (27.6%) and Hispanic were 1,100 (29.8%). Table 2 shows the frequencies of responses to the EQ-5D, HUI2 and HUI3 dimensions. The dominant response was ‘no problems’ (level 1) for all dimensions in all instruments, with a proportion larger than 90% for 1 out of 5 dimensions in EQ-5D (Self-Care), 1 out of 6 in HUI2 (Self-Care) and 3 out of 8 in HUI3 (Hearing, Speech, Dexterity). In all EQ-5D and HUI2 dimensions, frequencies decreased with increasing level severity. In the HUI3 Cognition dimension however, more respondents reported problems at level 3 (17.9%) and level 4 (7.4%) than at level 2 (4.1%). Although small, these differences also occurred in the HUI3 Vision and HUI3 Hearing dimensions.
Figure 2
Relative informativity (J′) was highest for EQ-5D in all common dimensions, with largest differences with the other two instruments in the dimensions Mobility/Ambulation (0.14 compared to HUI2; 0.16 compared to HUI3) and Anxiety/Depression/Emotion (0.14 compared to HUI2; 0.13 compared to HUI3). Table 3 shows Shannon’s indices by classification system as a whole. The EQ-5D, HUI2 and HUI3 descriptive systems distinguished 91, 322, and 694 observed different unique health states, accounting for 37.4%, 4.0%, and 0.07% of all possible permutations, respectively. The estimation procedure indicated that absolute informativity was highest for HUI3 (range 10.96–13.36), followed by HUI2 (range 8.57–9.48), and lowest for EQ-5D (range 6.24–6.41). Relative informativity was highest in EQ-5D (range 0.79–0.81), followed by HUI2 (range 0.66–0.73), and lowest for HUI3 (range 0.55–0.67).
Discussion We compared the discriminatory power of the EQ-5D, HUI2 and HUI3 in the general population, using Shannon’s indices of absolute and relative informativity, for each dimension separately and by MAUI as a whole. As might be expected in a general population sample, most respondents reported no problems on all dimensions and there were fewer responses with increasing level severity. An exception is HUI3 Cognition, where respondents reported more problems on levels 3 and 4 than on level 2. This is probably due to the fact that this dimension is not unidimensional, and levels 2 and 3 are conceptualized parallel rather than ordinal. That is, HUI3 Cognition level 2 focuses on problems in thinking and problem solving, level 3 addresses problems in remembering, whereas level 4 combines the problems mentioned in levels 2 and 3. Absolute informativity by dimension was highest for the HUI3 descriptive system. EQ-5D appears to underperform in the Pain/Discomfort dimension. Moreover, EQ-5D appears to miss a considerable ‘amount’ of disability: 61.3% of the population indicated to have no problems on EQ-5D, against 48.2% on HUI2 and 49.3% on HUI3 (Table 2). Shannon’s H′ ‘translated’ this difference adequately (Figure 2 For relative informativity by dimension, the EQ-5D descriptive system showed superior results in Mobility/Ambulation, Self-Care and Anxiety/Depression/Emotion. The large differences in Mobility/Ambulation could be due to a relatively large leap in the grading of the level descriptions in HUI3 Ambulation, where the difference between level 1 (‘without difficulty’) and level 2 (‘with difficulty’) can be considered disproportionately large in a 6 level dimension. The same leap from level 1 (‘normal’) to level 2 (‘with difficulty’) occurs in HUI2 Self-Care. We found that the 3 level EQ-5D Self Care outperformed the 4 level HUI2 Self-Care in both absolute and relative informativity (Fig. 2 Overall, performance in terms of informativity of EQ-5D, HUI2 and HUI3 of the common dimensions varies over dimensions. The Pain/Discomfort dimension of EQ-5D, but perhaps also other dimensions, might benefit from an extension to 4 or 5 levels. HUI2 and HUI3 might benefit from more sensitive grading terms in their level descriptions, especially the ‘threshold’ level 2, in Ambulation (HUI3) and Self-Care (HUI2). When assessing informativity by instrument, HUI3 shows the best results on absolute informativity but the lowest on relative informativity while EQ-5D shows highest relative informativity and lowest absolute informativity. HUI2 seems to be the optimal compromise. The importance of differences in the Shannon indices ultimately requires empirical evidence over a wider range of populations, conditions and instruments, including evidence on discriminant validity. As Shannon’s indices are new in the field of health status measurement, some methodological issues need to be addressed, taking into account that their principal focus is on classifications with mutually exclusive categories, rather than conventional (health status) measures which by design contain multiple partially overlapping items. The Shannon indices share some properties with reliability coefficients. Like reliability indices, they express discriminatory power. Furthermore, they are also non-dimensional, i.e. they have no relation to the content, meaning or clinical relevance of what the instrument aims to measure, which make them suitable for comparability, between instruments as well as between populations. However, reliability reflects two different concepts: discriminatory power as such, and consistency, e.g. consistency between raters (inter-rater reliability) or consistency over time (test-retest reliability). This requires a repeated measurement (repetition ‘over raters’ or over time) which introduces an error component in case of a difference among the repeated measurements. Shannon’s indices solely reflect discriminatory power, and need only a single measurement. Furthermore, the Shannon indices are non-parametric measures and therefore highly suitable for nominal or ordinal measurement scales. Since Shannon’s indices have no dimension and are independent of any external standard, a rectangular distribution is always the ideal from the perspective of informativity. When comparing the discriminatory power of similar dimensions of different MAUIs, rectangularity is always optimal as it reflects which MAUI is the most sensitive in discriminating between different persons in that particular population. This implies that one MAUI cannot be superior in varying populations (e.g. a general population and a diseased population sample). Furthermore, MAUIs are bound to score rather low on discriminatory power in a general population sample, as the extreme categories, which have to be included for coverage of the full spectrum of diseases, will not be endorsed frequently. Previously, the common approach to investigate discriminatory power was examining the frequency distributions of responses, e.g. for ceiling or floor effects. A comprehensive, formal measure to express discriminatory power such as Shannon’s indices seems clearly superior to such a ‘face-value’ method. Furthermore, when the number of categories is large (e.g. when comparing MAUIs as a whole), it becomes very difficult to make a sound comparison by just looking at the distributions. We have demonstrated the use of the Shannon indices to compare the discriminatory power of different MAUIs, to show which instrument is more sensitive in differentiating between levels of health in the population at hand. But they may also be used to guide the development of new, or optimization of existing MAUIs, by helping determine how many levels are efficient for each dimension. This is a particularly relevant consideration for MAUIs, since adding extra levels in a descriptive system makes it increasingly complex, and the derivation of a robust set of preference weights more challenging. Apart from MAUIs, the Shannon indices can also be used in a wide range of other classifications in the medical domain (e.g. the Karnofsky scale, the Spitzer QL index) and in the clinical domain (e.g. the APGAR score, the Child-Pugh classification). A practical weakness of the Shannon approach is that when the sample size is exceeded by the total number of health states described by all permutations across all dimensions of a MAUI, informativity (for the instrument as a whole) has to be estimated. This implies that using the Shannon Evenness index by instrument is not very practical when a health classification system has a large number of permutations as was the case in HUI3 (972,000 permutations). This however is not a disadvantage of the Shannon methodology per se, but also a matter of classification design (overload of dimensions with detailed response options producing an excessive amount of ‘empty’ permutations), or a practical problem (excessive data collection). From a clinical or psychometric perspective it may seem tempting to extend any MAUI with extra levels or dimensions as it provides more clinically relevant detail generally and improves reliability. But Shannon’s indices reveal that this may not always be a prudent approach. Increasing the number of levels per dimension (or permutations in the entire system) will probably result in higher H′ values but J′ values are likely to drop, as in fact our results for HUI3 indicate. This raises the question where the balance between H′ and J′ is optimal as more categories require more extensive subsequent studies to derive utility functions for the associated classification system. How the Shannon indices will behave in a different population, such as patient populations, remains to be investigated. So far, Shannon’s indices proved to be useful in showing weaknesses of level gradings used in EQ-5D, HUI2 and HUI3, and offers leads for improvement, establishing their practical psychometric value. Acknowledgements We would like to thank Stephen Joel Coons and James Shaw for assisting with the dataset. Part of the material presented in this paper was presented and discussed at the 2005 Annual EQ Meeting. We also thank Thomas Kohlmann for presenting a commented draft on part of our analysis, including a useful example in making the theory understandable. References 1. Guyatt, G. H., Feeny, D. H., & Patrick, D. L. (1993). Measuring health-related quality-of-life. Annals of Internal Medicine, 118, 622–629. [PubMed] 2. Mishoe, S. C., & Maclean, J. R. (2001). Assessment of health-related quality of life. Respiratory Care, 46, 1236–1257. [PubMed] 3. Brazier, J., Deverill, M., Green, C., Harper, R., & Booth, A. (1999). A review of the use of health status measures in economic evaluation. Health Technology Assessment, 3, 1–164. 4. Coons, S. J., Rao, S., Keininger, D. L., & Hays, R. D. (2000). A comparative review of generic quality-of-life instruments. Pharmacoeconomics, 17, 13–35. [PubMed] 5. Rabin R., de Charro F. (2001) EQ-5D: a measure of health status from the EuroQol Group. Annals of Medicine 33, 337–343. [PubMed] 6. Feeny, D., Furlong, W., & Torrance, G. (1999). The health utilities index: An update. Quality of Life Newsletter, 22, 8–9. 7. Horsman, J., Furlong, W., Feeny, D., & Torrance, G. (2003). The Health Utilities Index (HUI(R)): Concepts, measurement properties and applications. Health Qual Life Outcomes, 1, 54. [PubMed] 8. Brooks, R., Rabin, R. E., de Charro, F. Th. (2003). The measurement and valuation of health status using EQ-5D: A European perspective. Dordrecht: Kluwer academic publishers. 9. Furlong, W. J., Feeny, D. H., Torrance, G. W., & Barr, R. D. (2001). The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies. Annals of Medicine, 33, 375–384. [PubMed] 10. Kopec, J., & Willison, K. D. (2003). A comparative review of four preference-weighted measures of health-related quality of life. Journal of Clinical Epidemiology, 56, 317–325. [PubMed] 11. Brazier, J., & Deverill, M. (1999). A checklist for judging preference-based measures of health related quality of life: learning from psychometrics. Health Economics, 8, 41–51. [PubMed] 12. Brazier, J., Jones, N., & Kind, P. (1993). Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire. Quality of Life Research, 2, 169–80. [PubMed] 13. Sintonen, H. (2001). The 15D instrument of health-related quality of life: properties and applications. Annals of Medicine, 33, 328–336. [PubMed] 14. Murray, C. J., & Lopez, A. D. (2000). Progress and directions in refining the global burden of disease approach: a response to Williams. Health Economics, 9, 69–82. [PubMed] 15. Guyatt, H., Kirshner, B., & Jaeschke, R. (1992). Measuring health status: what are the necessary measurement properties? Journal of Clinical Epidemiology, 45, 1341–1345. [PubMed] 16. Streiner, D. L., & Norman, G. W. (1995). Health measurement scales: A practical guide to their development and use. Oxford: Oxford University Press. 17. Shannon, C. E (1948). A mathematical theory of communication. The Bell System Technical Journal, 27, 379–423. 18. Macran, S., Weatherly, H., & Kind, P. (2003). Measuring population health—A comparison of three generic health status measures. Medical Care, 41, 218–231. [PubMed] 19. Myers, C., & Wilks, D. (1999). Comparison of Euroqol EQ-5D and SF-36 in patients with chronic fatigue syndrome. Quality of Life Research, 8, 9–16. [PubMed] 20. Conner-Spady, B., & Suarez-Almazor, M. E. (2003). Variation in the estimation of quality-adjusted life-years by different preference-based instruments. Medical Care, 41, 791–801. [PubMed] 21. Shaw, J. W., Johnson, J. A., & Coons, S. J. (2005). US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Medical Care, 43, 203–220. [PubMed] 22. Johnson, J. A., Luo, N., Shaw, J. W., Kind, P., & Coons, S. J. (2005). Valuations of EQ-5D health states—Are the United States and United Kingdom different? Medical Care, 43, 221–228. [PubMed] 23. Furlong, W., Feeny, D., & Torrance, G. W. (2000). Health Utilities Index (HUI ®) procudures manual: algorithm for determining HUI Mark 2 (HUI2)/Mark 3 (HUI3) health status classification levels, health states, single attribute level utility scores and overall health-related quality of life utility scores, from 15-item self-complete health status questionnaires. Dundas: Ontario, Health Utilities Inc. 24. Shannon, C. E., & Weaver, W. (1949). The mathematical theory of communication. Urbana: University of Illinois Press. 25. Wiener, N. (1948). Cybernetics: or, control, and communication in the animal and the machine. Cambridge: MIT Press. 26. Krebs, C. J. (1989). Ecological methodology. New York: Harper & Row. 27. Miller, G. A, & Frick, F. C. (1949). Statistical behavioristics and sequences of responses. Psychological Review, 56, 311–24. [PubMed] 28. Reitsma, H. (1999). Registers in cardiovascular epidemiology. University of Amsterdam. 29. Rao, G. S., Hamid, Z., & Rao, J. S. (1979). The information content of DNA and evolution. Journal of Theoretical Biology, 81, 803–807. [PubMed] 30. Yockey, H. P. (1992). Information theory and molecular biology. Cambridge: Cambridge University Press. 31. Basharin, G. P. (1959). On a statistical estimate for the entropy of a sequence of independent random variables. Theory of Probability and its Applications, 4, 333–336. 32. Lloyd, M., & Ghelardi, R. J. (1964). A table for calculating the ’equitability’ component of species diversity. Journal of Animal Ecology, 33, 217–225. 33. Pielou, E. C. (1966). The measurement of diversity in different types of biological collections. Journal of Theoretical Biology, 13, 131–144. 34. Peet, R. K. (1974). The measurement of species diversity. Annual Review of Ecology and Systematics, 5, 285–307. 35. Mouillot, D., & Leprêtre, A. (1999). A comparison of species diversity estimators.Research on Population Ecology, 41, 203–215. |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||
Ann Intern Med. 1993 Apr 15; 118(8):622-9.
[Ann Intern Med. 1993]Respir Care. 2001 Nov; 46(11):1236-57.
[Respir Care. 2001]Pharmacoeconomics. 2000 Jan; 17(1):13-35.
[Pharmacoeconomics. 2000]Ann Med. 2001 Jul; 33(5):337-43.
[Ann Med. 2001]Health Qual Life Outcomes. 2003 Oct 16; 1():54.
[Health Qual Life Outcomes. 2003]Pharmacoeconomics. 2000 Jan; 17(1):13-35.
[Pharmacoeconomics. 2000]J Clin Epidemiol. 2003 Apr; 56(4):317-25.
[J Clin Epidemiol. 2003]Health Econ. 1999 Feb; 8(1):41-51.
[Health Econ. 1999]Qual Life Res. 1993 Jun; 2(3):169-80.
[Qual Life Res. 1993]Health Econ. 2000 Jan; 9(1):69-82.
[Health Econ. 2000]J Clin Epidemiol. 1992 Dec; 45(12):1341-5.
[J Clin Epidemiol. 1992]Qual Life Res. 1993 Jun; 2(3):169-80.
[Qual Life Res. 1993]Ann Med. 2001 Jul; 33(5):328-36.
[Ann Med. 2001]Med Care. 2003 Feb; 41(2):218-31.
[Med Care. 2003]Med Care. 2003 Jul; 41(7):791-801.
[Med Care. 2003]Med Care. 2005 Mar; 43(3):203-20.
[Med Care. 2005]Med Care. 2005 Mar; 43(3):221-8.
[Med Care. 2005]